OHI:NYE-Omega Healthcare Investors Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 37.72

Change

0.00 (0.00)%

Market Cap

USD 5.58B

Volume

1.22M

Analyst Target

USD 33.06
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Omega Healthcare Investors Inc is a self-administered real estate investment trust. The Company is engaged in investing in income-producing healthcare facilities, including long-term care facilities located in the United States and United Kingdom.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-0.08 (-0.06%)

USD 77.61B
VTR Ventas Inc

-0.38 (-0.65%)

USD 24.65B
DOC Healthpeak Properties Inc

-0.10 (-0.50%)

USD 14.07B
CTRE CareTrust REIT Inc.

-0.26 (-0.96%)

USD 5.07B
AHR American Healthcare REIT, Inc.

-0.15 (-0.53%)

USD 4.36B
NHI National Health Investors Inc

+0.09 (+0.13%)

USD 3.17B
LTC LTC Properties Inc

+0.02 (+0.06%)

USD 1.59B
CHCT Community Healthcare Trust Inc

+0.48 (+2.62%)

USD 0.52B
UHT Universal Health Realty Income..

-0.10 (-0.27%)

USD 0.51B
GMRE-PA Global Medical REIT Inc

-0.15 (-0.58%)

USD 0.40B

ETFs Containing OHI

SRET Global X SuperDividend® .. 4.63 % 0.59 %

-0.27 (0.27%)

USD 0.20B
BKGI BNY Mellon ETF Trust - BN.. 4.30 % 0.00 %

+0.08 (+0.27%)

N/A
CUBS 3.05 % 0.00 %

N/A

N/A
WSCR:LSE UBS (Irl) ETF plc - MSCI .. 0.54 % 0.00 %

-3.95 (0.27%)

USD 0.01B
UIMS:XETRA UBS (Irl) ETF plc - UBS (.. 0.54 % 0.00 %

-0.07 (0.27%)

USD 0.07B
WSCSRI:SW UBS (Irl) ETF plc - UBS (.. 0.54 % 0.00 %

-0.17 (0.27%)

USD 0.48B
BTAL AGFiQ U.S. Market Neutral.. 0.00 % 0.00 %

-0.59 (0.27%)

N/A
GRI GRI Bio Inc. 0.00 % 0.55 %

+0.02 (+0.27%)

N/A
HIPS GraniteShares HIPS US Hig.. 0.00 % 0.70 %

-0.07 (0.27%)

N/A
JKL iShares Morningstar Small.. 0.00 % 0.30 %

N/A

N/A
KBWY Invesco KBW Premium Yield.. 0.00 % 0.35 %

-0.07 (0.27%)

USD 0.23B
PSR Invesco Active U.S. Real .. 0.00 % 0.00 %

-0.41 (0.27%)

N/A
OLD 0.00 % 0.50 %

N/A

N/A
UXM.A:CA 0.00 % 1.49 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.03% 71% C- 81% B-
Dividend Return 8.74% 93% A 90% A-
Total Return 31.77% 79% B- 86% B+
Trailing 12 Months  
Capital Gain 23.03% 71% C- 81% B-
Dividend Return 8.74% 93% A 90% A-
Total Return 31.77% 79% B- 86% B+
Trailing 5 Years  
Capital Gain -9.65% 62% D 39% F
Dividend Return 32.10% 77% C+ 85% B
Total Return 22.44% 69% C- 50% F
Average Annual (5 Year Horizon)  
Capital Gain 2.65% 57% F 42% F
Dividend Return 10.42% 71% C- 60% D-
Total Return 7.77% 93% A 94% A
Risk Return Profile  
Volatility (Standard Deviation) 18.11% 71% C- 60% D-
Risk Adjusted Return 57.55% 79% B- 72% C
Market Capitalization 5.58B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.